Inhibitory Effect of Chlorogenic Acid on Low-Density Lipoprotein Oxidation Induced by Cu ion

  • Jeon, Eun-Raye (Department of Food Technology, Sunghwa College) ;
  • Karki, Rajendra (Department of Oriental Medicine Resources, Mokpo national University) ;
  • Kim, Dong-Wook (Department of Oriental Medicine Resources, Mokpo national University)
  • Received : 2010.05.17
  • Accepted : 2010.11.30
  • Published : 2010.12.31

Abstract

Chlorogenic acid, formed of an ester of caffeic acid and quinic acid, which is naturally abundant in many plant species, was used as a model O-dihydoxy phenolic compound. In the previous study, we have reported that the isolated constituent from Apocynum venetum leaves has an inhibitory effect on $Cu^{2+}$-induced oxidative modification of low-density lipoprotein (LDL). Among them, chlorogenic acid showed the most potent anti-LDL oxidative activity than other compounds. For the reason, we investigated the inhibitory effect of the chlorogenic acid on $Cu^{2+}$-induced oxidative modification of LDL, monitored a lag time in the conjugated-diene formation and TBARS formation, and measured TNBS free amino acid group, and form cell formation in vitro system. The TBARS- and diene- formation were strongly inhibited by chlorogenic acid ($0{\sim}100\;{\mu}g/ml$) with dose dependent manner. On the other hand, TNBS reactive lysine amino groups on LDL oxidation were protected by chlorogenic acid- treated cell group. Therefore, chlorogenic acid inhibited to cholesterol accumulation in the isolated peritoneal macrophage.

Keywords

References

  1. Chisolm GM and Steinberg D. 2000. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28(12):1815-26. https://doi.org/10.1016/S0891-5849(00)00344-0
  2. Craig WJ. 1999. Health-promoting properties of common herbs. Am J Clin Nutr 70 (3 Suppl.):491S-499S. https://doi.org/10.1093/ajcn/70.3.491s
  3. D.S. Leake. 1993. Oxidized low density lipoproteins and atherogenesis, Br. Heart J. 69: 476-478. https://doi.org/10.1136/hrt.69.6.476
  4. Ejzemberg R, Da Silva MH, Pinto L, and Mors WB. 1999. Action of chlorogenic acid on the complement system. An Acad BrasCienc 71: 273-277.
  5. Esterbauer H, Striegl G, Puhl H, and Rotheneder M. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 6(1): 67-75. https://doi.org/10.3109/10715768909073429
  6. Fowler, S., P. Berberian, H. Shio, S. Goldfischer, and H. Wolinsky. 1980. Characterization of cell populations isolated from aortas of rhesus monkeys with experimental atherosclerosis. Circ. Res 46: 520-530. https://doi.org/10.1161/01.RES.46.4.520
  7. Friedman M.1999. Chemistry, biochemistry, and dietry role of potato polyphenols. J Agric Food Chem 45:1523-1540.
  8. Fuhrman B and Aviram M. 2001. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 12(1):41-8. https://doi.org/10.1097/00041433-200102000-00008
  9. Giugliano D. 2000. Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovasc 10(1):38-44.
  10. Hoffman R., Brook J G., and Aviram M. 1992. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis 93(1-2):105-113. https://doi.org/10.1016/0021-9150(92)90204-T
  11. Hussein O, Schlezinger S, Rosenblat M, Keidar S, and Aviram M. 1997. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis 128(1):11-8. https://doi.org/10.1016/S0021-9150(96)05972-2
  12. Jerome, W. G., and J. and C. Lewis. 1985. Early atherogenesis in White Carneau pigeons. II. Ultrastructural and cytochemical observations. Am. J. Pathol 119: 210-222.
  13. Jerome, W. G., and J. C. Lewis. 1984. Early atherogenesis in White Carneau pigeons. I. Leukocyte margination and endothelial alterations at the celiac bifurcation. Am. J. Pathol. 116: 56-68.
  14. Jiang Y, Kusama K, and Satoh K. 2000a. Induction of cytotoxicity by chlorogenic acid in human oral tumor cell lines. Phytomedicine 7: 483-491. https://doi.org/10.1016/S0944-7113(00)80034-3
  15. Jiang Y, Satoh K, and Kusama K. 2000b. Interaction between chlorogenic acid and antioxidants. Anticancer Res 20: 2473-2476.
  16. J.L. Witztum, and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis, J. Clin. Invest 88: 1785-1792. https://doi.org/10.1172/JCI115499
  17. Kim DW, Yokozawa T, Hattori M, Kadota S, and Namba T. 2000. Inhibitory effects of an aqueous extract of Apocynum venetum leaves and its constituents on Cu(2+)-induced oxidative modification of low density lipoprotein. Phytother Res 14(7): 501-504. https://doi.org/10.1002/1099-1573(200011)14:7<501::AID-PTR655>3.0.CO;2-B
  18. Kleinveld HA, Naber AH, Stalenhoef AF, and Demacker PN. 1993. Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Radic Biol Med 15(3): 273-80. https://doi.org/10.1016/0891-5849(93)90074-5
  19. Kono Y, Kobayashi K, and Tagawa S. 1997. Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive spieces of oxygen and nitrogen. Biochim Biophys Acta 1335: 335-342. https://doi.org/10.1016/S0304-4165(96)00151-1
  20. Lavy A, Ben Amotz A, and Aviram M. 1993. Preferential inhibition of LDL oxidation by the all-trans isomer of beta-carotene in comparison with 9-cis beta-carotene. Eur J Clin Chem Clin Biochem 31(2):83-90.
  21. Lowry OH, Rosebrough NJ, Farral AL, and Ranall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-75.
  22. M. Shaikh, S. Martini, J.R. Quiney, P. Baskerville, A.E. La Ville, N.L. Brows, R. Duffield, P.R. Turner, and B. Lewis. 1988. Modified plasma derived lipoproteins in human atherosclerosis plaques. Atherosclerosis 69: 165-172. https://doi.org/10.1016/0021-9150(88)90011-1
  23. Sato K, Niki E, and Shimasaki H. 1990. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C.Arch Biochem Biophys 279(2):402-405. https://doi.org/10.1016/0003-9861(90)90508-V
  24. S. Parthasarathy, and S.M. Rankin. 1992. Role of oxidized low density lipoprotein in atherogenesis. Proc. Lipid Res 31: 127-143. https://doi.org/10.1016/0163-7827(92)90006-5
  25. Steinberg, D., S. Parthasarathy, T. Carew, J. Khoo, and J. Witztum. 1989. Beyond cholesterol, modification of lowdensity lipoproteins that increase its atherogenicity. N. Engl. J. Med 320: 915-924. https://doi.org/10.1056/NEJM198904063201407
  26. Tanaka T, Nishikawa A, and Shima H. 1990. Inhibitory effects of chlorogenic acid, resperpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 52: 429-440.
  27. U.P. Steinbrecher, G. Zhang, and M. Lougheed. 1990. Role of oxidatively modified LDL in atherosclerosis, Free Rad. Biol. Med 9 :155-168.
  28. Weber C, and Erl W. 2000. Modulation of vascular cell activation, function, and apoptosis: role of antioxidants and nuclear factor kappa B. Curr Top Cell Regul 36:217-35.
  29. Yla-Herttuala, S., W. Palinski, M. Rosenfield, S. Parthasarathy, T. Carew, S. Butler, J.L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095. https://doi.org/10.1172/JCI114271